Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radiopharmaceuticals for cardiac imaging.

D D Miller, D R Elmaleh, K A McKusick

    Radiologic Clinics of North America
    |December 1, 1985
    PubMed
    Summary

    New radiopharmaceuticals enhance nuclear medicine diagnostics for cardiac diseases. These agents improve assessment of myocardial perfusion, ventricular function, necrosis, and metabolism in ischemic heart disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Restriction Fragment Length Polymorphism Analyses of Iranian Strains of Xanthomonas campestris from Cereals and Grasses.

    Plant disease·2019
    Same author

    Treatment of hepatitis C monoinfection in adults--Dutch national guidelines.

    The Netherlands journal of medicine·2013
    Same author

    Prediction of response to antiretroviral therapy by human experts and by the EuResist data-driven expert system (the EVE study).

    HIV medicine·2010
    Same author

    The parish pump [venereal disease control].

    Health education journal·2010
    Same author

    Oseltamivir-resistant influenza A(H1N1) viruses detected in Europe during season 2007-8 had epidemiologic and clinical characteristics similar to co-circulating susceptible A(H1N1) viruses.

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2009
    Same author

    Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase.

    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2009

    Area of Science:

    • Cardiovascular medicine
    • Nuclear medicine
    • Radiopharmaceutical science

    Background:

    • Traditional nuclear medicine methods for cardiac assessment include thallium-201 scintigraphy for myocardial perfusion and technetium-99m radioangiography for ventricular function.
    • Advancements in radiopharmaceutical development are crucial for improving diagnostic accuracy in cardiovascular diseases.

    Purpose of the Study:

    • To summarize the radiochemistry, dosimetry, and clinical utility of novel radiopharmaceuticals for nuclear cardiology.
    • To compare these new agents with established methods for evaluating myocardial perfusion and ventricular function.
    • To present emerging techniques for assessing myocardial necrosis and metabolism.

    Main Methods:

    • Review of radiochemistry, dosimetry, and clinical data for new radiopharmaceuticals.

    Related Experiment Videos

  • Comparative analysis against thallium-201 scintigraphy and technetium-99m radioangiography.
  • Presentation of techniques utilizing radiolabeled antimyosin antibody and fatty acid analogues.

    • Main Results:

    • New radiopharmaceuticals offer increased diagnostic utility in nuclear medicine for cardiac conditions.
    • These agents provide a comprehensive evaluation of myocardial perfusion, ventricular function, necrosis, and metabolism.
    • Specific focus on radiolabeled antimyosin antibody and fatty acid analogues for ischemic heart disease.

    Conclusions:

    • Novel radiopharmaceuticals represent a significant advancement in nuclear cardiology diagnostics.
    • These agents enhance the assessment of various aspects of heart disease, including perfusion, function, necrosis, and metabolism.
    • Emerging techniques show promise for improved management of ischemic heart disease.